| __timestamp | Alpine Immune Sciences, Inc. | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 51796000 |
| Thursday, January 1, 2015 | 16054000 | 72758000 |
| Friday, January 1, 2016 | 23316000 | 61008000 |
| Sunday, January 1, 2017 | 10626000 | 66962000 |
| Monday, January 1, 2018 | 28970000 | 84888000 |
| Tuesday, January 1, 2019 | 35847000 | 107068000 |
| Wednesday, January 1, 2020 | 27185000 | 122964000 |
| Friday, January 1, 2021 | 58742000 | 208808000 |
| Saturday, January 1, 2022 | 70243000 | 253297000 |
| Sunday, January 1, 2023 | 80904000 | 216566000 |
Unlocking the unknown
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Alpine Immune Sciences, Inc. and BioCryst Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, BioCryst consistently outspent Alpine, with its R&D expenses peaking at over 250% higher than Alpine's in 2022. Notably, Alpine's R&D spending surged by approximately 560% from 2014 to 2023, reflecting a strategic pivot towards aggressive innovation. Meanwhile, BioCryst's investment grew by around 320% during the same period, underscoring its sustained commitment to research. This data highlights the dynamic nature of biotech innovation, where strategic R&D investments can significantly influence a company's trajectory and market position.
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: argenx SE vs BioCryst Pharmaceuticals, Inc.
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Research and Development Investment: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs BioCryst Pharmaceuticals, Inc.